2012 annual financial data

Neuphoria Therapeutics 2012 Net margin

Direct answer

Net margin was -60.04%.

Operating income was -12.21M USD and net income was -3.21M USD.
Operating cash flow was -2.95M USD.

Get free Neuphoria Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
5.35M USD
Operating income
-12.21M USD
Net income
-3.21M USD
Operating cash flow
-2.95M USD